A Comprehensive Analysis of Bleeding Outcomes with Aspirin Removal with a Fully Magnetically Levitated LVAD - The International Randomized Controlled ARIES Trial
Purpose: Although hemocompatibility related adverse events including pump thrombosis and stroke have been reduced with introduction of a fully magnetically levitated LVAD, the incidence of non-surgical bleeding remains high. Whether aspirin, as part of an antithrombotic regimen including Vitamin-K Antagonist (VKA) may be safely removed and if it reduces the residual risk of non-surgical bleeding complications remains unknown.
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Authors: , M.R. Mehra Source Type: research
More News: Aspirin | Bleeding | Cardiology | Heart | Heart Transplant | Lung Transplant | Stroke | Thrombosis | Transplant Surgery | Transplants | Vitamin K | Vitamins